A new clinical trial has found that doxycycline, a widely available antibiotic, can help prevent already hospitalized COVID-19 patients from worsening to the point that they need intensive care.
Sold in the United States under brand names such as Acticlate, Vibramycin, and Oracea, doxycycline has been widely used to treat pneumonia caused by bacteria. It’s also used to treat and prevent anthrax, a serious skin and lung infection notoriously associated with biological warfare.
